Phase I/II Trial of Anticarcinoembryonic Antigen Radioimmunotherapy, Gemcitabine, and Hepatic Arterial Infusion of Fluorodeoxyuridine Postresection of Liver Metastasis for Colorectal Carcinoma

Objectives: Report the feasibility, toxicities, and long-term results of a Phase I/II trial of (90)Y-labeled anticarcinoembryonic antigen (anti-CEA) (cT84.66) radioimmunotherapy (RIT), gemcitabine, and hepatic arterial infusion (HAI) of fluorodeoxyuridine (FUdR) after maximal hepatic resection of me...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Biother Radiopharm
Main Authors: Cahan, Benjamin, Leong, Lucille, Wagman, Lawrence, Yamauchi, David, Shibata, Stephen, Wilzcynski, Sharon, Williams, Lawrence E., Yazaki, Paul, Colcher, David, Frankel, Paul, Wu, Anna, Raubitschek, Andrew, Shively, John, Wong, Jeffrey Y.C.
Formato: Artigo
Idioma:Inglês
Publicado em: Mary Ann Liebert, Inc. 2017
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5646801/
https://ncbi.nlm.nih.gov/pubmed/28910150
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/cbr.2017.2223
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados